CinCor Pharma
Why Robinhood?
You can watch CinCor Pharma and buy or sell other stocks, ETFs, and their options commission-free!About CINC
CinCor Pharma, Inc. operates as a clinical-stage biopharmaceutical company focused on developing its clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases. The firm is developing CIN-107 for the treatment of multiple diseases where aldosterone plays a significant role in disease pathophysiology, including hypertension and primary aldosteronism, as well as its utility in ameliorating complications of chronic kidney disease.
CINC Key Statistics
Stock Snapshot
CinCor Pharma(CINC) stock is priced at $29.06, giving the company a market capitalization of 1.27B. It carries a P/E multiple of -12.67.
On 2026-10-26, CinCor Pharma(CINC) stock opened at —, reached a high of —, and a low of —.
CinCor Pharma(CINC) shares are trading with a volume of 0, against a daily average of 1.2M.
During the past year, CinCor Pharma(CINC) stock moved between $10.53 at its lowest and $43.15 at its peak.
During the past year, CinCor Pharma(CINC) stock moved between $10.53 at its lowest and $43.15 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.